Novo Nordisk NVO Balance Sheet

Income Statement

Quarter End	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	DKK (kr)	DKK (kr)	DKK (kr)	DKK (kr)	DKK (kr)	DKK (kr)	DKK (kr)	DKK (kr)
Total Assets	241.26B	250.03B	280.75B	300.1B	314.49B	298.92B	369.38B	397.44B
Total Current Assets	108.19B	113.94B	137.55B	142.2B	139.65B	116.42B	177.5B	195.16B
Cash and Equivalents	12.65B	14.94B	21.57B	30.14B	14.39B	6.32B	52.82B	57.02B
Total Non-Current Assets	199.73B	206.1B	218.23B	239.36B	265.8B	280.73B	301.86B	322.11B
Total Liabilities	157.77B	170.15B	190.28B	207.11B	207.93B	200.01B	256.86B	276.92B
Total Current Liabilities	120.94B	131.96B	156.62B	172.55B	169.66B	165.61B	187.91B	208.36B
Total Non-Current Liabilities	61.15B	62.46B	53.08B	54.48B	58.8B	51.17B	120.56B	120.01B
Common Equity	456M	456M	451M	451M	451M	451M	446M	446M
Retained Earnings	80.59B	77.07B	88.12B	91.74B	104.84B	99.05B	112.15B	121.67B

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	DKK (kr)	DKK (kr)	DKK (kr)	DKK (kr)	DKK (kr)	DKK (kr)	DKK (kr)	DKK (kr)
Total Assets	97.54B	102.36B	110.77B	125.61B	144.92B	194.51B	241.26B	314.49B
Total Current Assets	59.77B	60.08B	59.07B	62.46B	65.81B	85.6B	108.19B	139.65B
Cash and Equivalents	18.69B	18.85B	15.64B	15.48B	12.76B	10.72B	12.2B	14.39B
Total Non-Current Assets	45.27B	49.82B	51.84B	57.59B	63.33B	70.75B	83.49B	106.56B
Total Liabilities	52.27B	52.54B	58.93B	68.02B	81.6B	123.76B	157.77B	207.93B
Total Current Liabilities	47.44B	47.06B	54.16B	58.98B	70.27B	99.52B	120.94B	169.66B
Total Non-Current Liabilities	4.83B	5.48B	4.77B	12.05B	14.22B	37.21B	61.15B	58.8B
Total Equity	45.27B	49.82B	51.84B	57.59B	63.33B	70.75B	83.49B	106.56B
Common Equity	510M	500M	490M	480M	470M	462M	456M	451M
Retained Earnings	46.11B	48.98B	53.41B	57.82B	63.77B	72B	80.59B	104.84B